Etiometry Significantly Enhances Platform Capabilities, Extending Insights Beyond the ICU
News and Press Releases
The addition of high-fidelity waveform data integration provides deeper insights and additional data points available in lower-acuity settings
July 8, 2025 – BOSTON – Etiometry, a leader in clinical decision support software, has announced a significant advancement to its platform with the integration of high-fidelity waveform data to inform and improve existing clinical data interpretation.
By leveraging waveform information alongside existing data streams, including patient monitors, peripheral devices, lab results, and medication data—this enhancement offers deeper insights into patient physiology, enabling clinicians to make even more informed decisions at the point of care. Using this robust data stream, Etiometry’s proprietary FDA-cleared algorithms can now generate novel clinical insights beyond the ICU—extending into lower-acuity settings where waveform data serves as the primary source of patient information.
“This new capability marks a pivotal step in expanding the reach of the Etiometry Platform beyond intensive care, supporting clinical surveillance in lower-acuity settings and across transitions of care within the hospital,” said Etiometry President and CEO Shane Cooke. “With these enhancements, Etiometry continues to advance its mission of improving patient outcomes by delivering scalable, data-driven insights throughout the entire continuum of hospital care.”
The enhancements further expand Etiometry’s robust quality improvement (QI) application by storing the high-fidelity waveform data, making it available for ongoing research. At an enterprise level, clinicians are now able to utilize the platform to monitor patients in their end-to-end journey as they transition care settings within the hospital and extract meaningful data insights. The Etiometry QI App has supported more than 150 quality improvement initiatives and research projects, demonstrating the platform’s role in enhancing healthcare delivery and enabling clinicians to drive better patient outcomes.
###
About Etiometry
Founded in 2010, Etiometry is a leader in clinical decision-support software designed to help clinicians in intensive care units make data-driven, proactive decisions. By leveraging advanced analytics and AI-powered insights, the company empowers care teams to detect subtle changes in patient conditions, prevent complications, and improve recovery times.
Etiometry has received 10 FDA clearances and is trusted by leading healthcare institutions worldwide, including top-ranked academic medical centers and pediatric hospitals. The company is committed to advancing patient safety, improving clinical efficiency, and lowering the cost of care through smarter data utilization.
To learn more, visit www.etiometry.com.
Media Contact
Hyedi Nelson
Bellmont Partners
Hyedi@bellmontpartners.com
651-757-7054
Related
First Automated Hospital-Specific Cardiogenic Shock Classification Tool for Critical Care Teams
Etiometry has received FDA clearance (K254066) for the Etiometry Cardiogenic Shock Tool: the first-ever automated solution for hospital-specific cardiogenic shock classification and tracking (aligned with each institution’s own protocols) using physiologic monitoring data. This is Etiometry’s 11th FDA clearance overall, and the only solution that automates SCAI staging directly from physiologic monitoring data. For cardiac […]
Etiometry Receives a First-Ever FDA Clearance for Automating Hospital-Specific Cardiogenic Shock Classification and Tracking
BOSTON, Mass. – April 8, 2026 – Etiometry, a leader in AI-driven clinical intelligence, today announced it has received FDA clearance (K254066) for the first-ever solution for automation of hospital-specific cardiogenic shock classification and tracking by directly utilizing data from physiologic monitoring, the Etiometry Cardiogenic Shock Tool. Cardiogenic shock remains a critical challenge, with delayed identification […]
Boston Children’s enhances care with clinical intelligence platform
At Boston Children’s Hospital, Dr. Peter Laussen and Dr. Joshua Salvin are leading the way as true pioneers in clinical intelligence and AI. Through ongoing collaboration, their work has evolved to better integrate and interpret complex patient data, helping care teams shift toward more informed, data-driven decision-making in real time. Read how they helped shape […]